Cronos Group (CRON)
Branded cannabis portfolio across Canada, Israel, and other international markets.
Something off on this page? Send us feedback.
Sells cannabis flower and extracts under Spinach, PEACE NATURALS, and Lord Jones across Canada, Israel, and other international markets. Its current consumer-brand business follows exits from U.S. hemp-derived products and fermentation-based manufacturing.
Sells branded cannabis products through Spinach, PEACE NATURALS, and Lord Jones, including flower, pre-rolls, vaporizers, edibles, and tinctures in their applicable markets. Revenue comes from cannabis flower and extracts in Canada, Israel, and other international markets. Its portfolio spans multiple legal-market product forms.
Operates after a multiyear reset that ended U.S. hemp-derived cannabinoid sales and fermentation-based cannabinoid manufacturing. Current operations are organized around legal cannabis markets and consumer brands rather than former hemp and fermentation businesses. A proposed acquisition of Dutch CanAdelaar remained pending, subject to regulatory and other closing conditions.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jan 14, 2026 | Bernstein | Target | Target: — | Target: $2.30 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $797.0M · Total debt $1.3M · Total assets $1.18B · Shareholders' equity $1.07B
- Revenue
- $70.6M
- Operating income
- $7.4M
- Net income
- $32.1M
No dividends on record.
| Institutions | 12.88% | 47.46M shares | |
|---|---|---|---|
| 206 holders · as of Jun 30, 2026 | |||
| Insiders | 8.20% | 30.21M shares | |
| 12 holders · as of May 14, 2026 | |||
| Other | 78.92% | 290.74M shares | |
| remainder | |||
368.41M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Jason AdlerInsider | 4.15% | 15.28M | filed Apr 4, 2019 |
Michael Ryan GorensteinInsiderdirector, officer: See remarks below | 3.59% | 13.21M | filed Mar 17, 2026 |
D. E. Shaw & Co., Inc.Institution | 2.40% | 8.84M | as of Jun 30, 2026 |
Chescapmanager LLCInstitution | 2.16% | 7.94M | as of Jun 30, 2026 |
Toroso Investments, LLCInstitution | 1.02% | 3.77M | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- Tilray Brands
Canadian adult-use, medical, and international cannabis portfolio
- Canopy Growth
Canadian adult-use, medical, and international cannabis portfolio
- Organigram Global
Canadian adult-use cannabis across multiple product formats
- Aurora Cannabis
Canadian and global medical cannabis with limited consumer sales
- InterCure
Israel-focused medical cannabis with German market expansion
- Village Farms International
Branded Canadian flower portfolio with international medical exports
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Cronos Group | $3.44 | +3.15% | $1.24B | 18.4 | 57.3 | 5.1 | +58.4% |
| Tilray Brands | $4.27 | +4.53% | $456.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9602 | +3.94% | $390.0M | — | — | 1.7 | −20.8% |
| Organigram Global | $1.12 | +0.08% | $157.7M | 2.5 | 37.5 | 0.7 | +43.2% |
| Aurora Cannabis | $4.20 | +4.09% | $249.6M | — | — | 1.2 | −34.0% |
| InterCure | $5.44 | +3.62% | $62.1M | — | — | — | — |
| Village Farms International | $3.04 | +5.38% | $350.8M | 15.3 | 15.3 | 1.5 | +6.8% |
| Median | 8.9 | 26.4 | 1.2 | +6.8% |